Literature DB >> 11288515

Mycobacterium ulcerans in wild animals.

F Portaels1, K Chemlal, P Elsen, P D Johnson, J A Hayman, J Hibble, R Kirkwood, W M Meyers.   

Abstract

Mycobacterium ulcerans infection, or Buruli ulcer, is the third most frequent mycobacterial disease in humans, often causing serious deformities and disability. The disease is most closely associated with tropical wetlands, especially in west and central Africa. Most investigators believe that the aetiological agent proliferates in mud beneath stagnant waters. Modes of transmission may involve direct contact with the contaminated environment, aerosols from water surfaces, and water-dwelling fauna (e.g. insects). Person-to-person transmission is rare. Trauma at the site of skin contamination by M. ulcerans appears to play an important role in initiating disease. Once introduced into the skin or subcutaneous tissue, M. ulcerans multiplies and produces a toxin that causes necrosis. However, the type of disease induced varies from a localised nodule or ulcer, to widespread ulcerative or non-ulcerative disease and osteomyelitis. Although culture of M. ulcerans from a patient was first reported in 1948, attempts to culture the mycobacterium from many specimens of flora and fauna have been unsuccessful. Failure to cultivate this organism from nature may be attributable to inadequate sampling, conditions of transport, decontamination and culture of this fastidious heat-sensitive organism, and to a long generation time relative to that of other environmental mycobacteria. Nevertheless, recent molecular studies using specific primers have revealed M. ulcerans in water, mud, fish and insects. Although no natural reservoir has been found, the possibility that M. ulcerans may colonise microfauna such as free-living amoebae has not been investigated. The host range of experimental infection by M. ulcerans includes lizards, amphibians, chick embryos, possums, armadillos, rats, mice and cattle. Natural infections have been observed only in Australia, in koalas, ringtail possums and a captive alpaca. The lesions were clinically identical to those observed in humans. Mycobacterium ulcerans infection is a rapidly re-emerging disease in some developing tropical countries. The re-emergence may be related to environmental and socioeconomic factors, for example, deforestation leading to increased flooding, and population expansion without improved agricultural techniques, thus putting more people at risk. Eradication of diseases related to these factors is difficult. Whether wild animals have a role in transmission is an important question that, to date, has been virtually unexplored. To address this question, surveys of wild animals are urgently required in those areas in which Buruli ulcer is endemic.

Entities:  

Mesh:

Year:  2001        PMID: 11288515     DOI: 10.20506/rst.20.1.1270

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  64 in total

1.  Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.

Authors:  Marie-Thérèse Ruf; Daniela Schütte; Aurélie Chauffour; Vincent Jarlier; Baohong Ji; Gerd Pluschke
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Community-based geographical distribution of Mycobacterium ulcerans VNTR-genotypes from the environment and humans in the Nyong valley, Cameroon.

Authors:  Francis Zeukeng; Anthony Ablordey; Solange E Kakou-Ngazoa; Stephen Mbigha Ghogomu; David N'golo Coulibaly; Marie Thérèse Ngo Nsoga; Wilfred Fon Mbacham; Jude Daiga Bigoga; Rousseau Djouaka
Journal:  Trop Med Health       Date:  2021-05-21

3.  Genotyping Mycobacterium ulcerans and Mycobacterium marinum by using mycobacterial interspersed repetitive units.

Authors:  Pieter Stragier; Anthony Ablordey; Wayne M Meyers; Françoise Portaels
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

4.  Evolution of Mycobacterium ulcerans and other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitor.

Authors:  Marcus J Yip; Jessica L Porter; Janet A M Fyfe; Caroline J Lavender; Françoise Portaels; Martha Rhodes; Howard Kator; Angelo Colorni; Grant A Jenkin; Tim Stinear
Journal:  J Bacteriol       Date:  2006-12-15       Impact factor: 3.490

5.  Interaction of Mycobacterium ulcerans with mosquito species: implications for transmission and trophic relationships.

Authors:  John R Wallace; Matthew C Gordon; Lindsey Hartsell; Lydia Mosi; M Eric Benbow; Richard W Merritt; Pamela L C Small
Journal:  Appl Environ Microbiol       Date:  2010-07-30       Impact factor: 4.792

6.  Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease.

Authors:  F Portaels; J Aguiar; M Debacker; A Guédénon; C Steunou; C Zinsou; W M Meyers
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Aquatic insects as a vector for Mycobacterium ulcerans.

Authors:  Laurent Marsollier; Raymond Robert; Jacques Aubry; Jean-Paul Saint André; Henri Kouakou; Pierre Legras; Anne-Lise Manceau; Chetaou Mahaza; Bernard Carbonnelle
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

8.  A major role for mammals in the ecology of Mycobacterium ulcerans.

Authors:  Janet A M Fyfe; Caroline J Lavender; Kathrine A Handasyde; Alistair R Legione; Carolyn R O'Brien; Timothy P Stinear; Sacha J Pidot; Torsten Seemann; M Eric Benbow; John R Wallace; Christina McCowan; Paul D R Johnson
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

9.  Family relationship, water contact and occurrence of Buruli ulcer in Benin.

Authors:  Ghislain Emmanuel Sopoh; Yves Thierry Barogui; Roch Christian Johnson; Ange Dodji Dossou; Michel Makoutodé; Sévérin Y Anagonou; Luc Kestens; Françoise Portaels
Journal:  PLoS Negl Trop Dis       Date:  2010-07-13

Review 10.  Identifying reservoirs of infection: a conceptual and practical challenge.

Authors:  Daniel T Haydon; Sarah Cleaveland; Louise H Taylor; M Karen Laurenson
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.